181 related articles for article (PubMed ID: 11005847)
1. Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin.
González C; Langdon GM; Bruix M; Gálvez A; Valdivia E; Maqueda M; Rico M
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11221-6. PubMed ID: 11005847
[TBL] [Abstract][Full Text] [Related]
2. Peptide AS-48: prototype of a new class of cyclic bacteriocins.
Maqueda M; Gálvez A; Bueno MM; Sanchez-Barrena MJ; González C; Albert A; Rico M; Valdivia E
Curr Protein Pept Sci; 2004 Oct; 5(5):399-416. PubMed ID: 15544535
[TBL] [Abstract][Full Text] [Related]
3. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B.
Andersson M; Curstedt T; Jörnvall H; Johansson J
FEBS Lett; 1995 Apr; 362(3):328-32. PubMed ID: 7729523
[TBL] [Abstract][Full Text] [Related]
4. Design, NMR characterization and activity of a 21-residue peptide fragment of bacteriocin AS-48 containing its putative membrane interacting region.
Jiménez MA; Barrachi-Saccilotto AC; Valdivia E; Maqueda M; Rico M
J Pept Sci; 2005 Jan; 11(1):29-36. PubMed ID: 15635724
[TBL] [Abstract][Full Text] [Related]
5. Identification of an anti-mycobacterial domain in NK-lysin and granulysin.
Andreu D; Carreño C; Linde C; Boman HG; Andersson M
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):845-9. PubMed ID: 10585872
[TBL] [Abstract][Full Text] [Related]
6. Comparative modeling of amoebapores and granulysin based on the NK-lysin structure-structural and functional implications.
Bruhn H; Leippe M
Biol Chem; 1999; 380(7-8):1001-7. PubMed ID: 10494853
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of amoebapore and NK-lysin: a four-alpha-helix bundle motif of cytolytic peptides from distantly related organisms.
Dandekar T; Leippe M
Fold Des; 1997; 2(1):47-52. PubMed ID: 9080198
[TBL] [Abstract][Full Text] [Related]
8. Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin.
Miteva M; Andersson M; Karshikoff A; Otting G
FEBS Lett; 1999 Nov; 462(1-2):155-8. PubMed ID: 10580110
[TBL] [Abstract][Full Text] [Related]
9. Effect of replacing glutamic residues upon the biological activity and stability of the circular enterocin AS-48.
Sánchez-Hidalgo M; Martínez-Bueno M; Fernández-Escamilla AM; Valdivia E; Serrano L; Maqueda M
J Antimicrob Chemother; 2008 Jun; 61(6):1256-65. PubMed ID: 18385141
[TBL] [Abstract][Full Text] [Related]
10. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity.
Andersson M; Holmgren A; Spyrou G
J Biol Chem; 1996 Apr; 271(17):10116-20. PubMed ID: 8626570
[TBL] [Abstract][Full Text] [Related]
11. Saposin fold revealed by the NMR structure of NK-lysin.
Liepinsh E; Andersson M; Ruysschaert JM; Otting G
Nat Struct Biol; 1997 Oct; 4(10):793-5. PubMed ID: 9334742
[TBL] [Abstract][Full Text] [Related]
12. A NK-lysin from Cynoglossus semilaevis enhances antimicrobial defense against bacterial and viral pathogens.
Zhang M; Long H; Sun L
Dev Comp Immunol; 2013; 40(3-4):258-65. PubMed ID: 23524198
[TBL] [Abstract][Full Text] [Related]
13. Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin.
Andrä J; Leippe M
Med Microbiol Immunol; 1999 Dec; 188(3):117-24. PubMed ID: 10776841
[TBL] [Abstract][Full Text] [Related]
14. Interaction of amoebapores and NK-lysin with symmetric phospholipid and asymmetric lipopolysaccharide/phospholipid bilayers.
Gutsmann T; Riekens B; Bruhn H; Wiese A; Seydel U; Leippe M
Biochemistry; 2003 Aug; 42(32):9804-12. PubMed ID: 12911324
[TBL] [Abstract][Full Text] [Related]
15. Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis.
Bruhn H; Riekens B; Berninghausen O; Leippe M
Biochem J; 2003 Nov; 375(Pt 3):737-44. PubMed ID: 12917014
[TBL] [Abstract][Full Text] [Related]
16. Lipid membrane binding of NK-lysin.
Ruysschaert JM; Goormaghtigh E; Homblé F; Andersson M; Liepinsh E; Otting G
FEBS Lett; 1998 Mar; 425(2):341-4. PubMed ID: 9559676
[TBL] [Abstract][Full Text] [Related]
17. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.
Andersson M; Gunne H; Agerberth B; Boman A; Bergman T; Sillard R; Jörnvall H; Mutt V; Olsson B; Wigzell H
EMBO J; 1995 Apr; 14(8):1615-25. PubMed ID: 7737114
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the predicted structures of domain 1 of protein g3 (T0030) and NK-lysin (T0042).
Osguthorpe DJ
Proteins; 1997; Suppl 1():172-8. PubMed ID: 9485509
[TBL] [Abstract][Full Text] [Related]
19. Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite.
Leippe M
Cell; 1995 Oct; 83(1):17-8. PubMed ID: 7553868
[No Abstract] [Full Text] [Related]
20. Conserved structure and function in the granulysin and NK-lysin peptide family.
Linde CM; Grundström S; Nordling E; Refai E; Brennan PJ; Andersson M
Infect Immun; 2005 Oct; 73(10):6332-9. PubMed ID: 16177304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
